These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 5955980)

  • 1. Comparative metabolic studies with Natulan, methylhydrazine and methylamine in rats.
    Schwartz DE
    Experientia; 1966 Apr; 22(4):212-3. PubMed ID: 5955980
    [No Abstract]   [Full Text] [Related]  

  • 2. Demethylation in vivo of Natulan, a tumour-inhibiting methylhydrazine derivative.
    Baggiolini M; Bickel MH; Messiha FS
    Experientia; 1965 Jun; 21(6):334-6. PubMed ID: 5870507
    [No Abstract]   [Full Text] [Related]  

  • 3. [Studies with 3H-labeled methylhydrazine derivatives].
    Kleibel F
    Nucl Med (Stuttg); 1965; 2():63-7. PubMed ID: 5888981
    [No Abstract]   [Full Text] [Related]  

  • 4. Distribution and excretion studies of procarbazine in animals and man.
    Schwartz DE; Bollag W; Obrecht P
    Arzneimittelforschung; 1967 Nov; 17(11):1389-93. PubMed ID: 5632152
    [No Abstract]   [Full Text] [Related]  

  • 5. N-demethylation of p-(N1-methylhydrazion methyl)-N-isopropyl benzamide (procarbazine), a cytostatically active methylhydrazine derivative, in the intact rat and in the isolated perfused rat liver.
    Dewald B; Baggiolini M; Aebi H
    Biochem Pharmacol; 1969 Sep; 18(9):2179-86. PubMed ID: 5345891
    [No Abstract]   [Full Text] [Related]  

  • 6. [Induction and inhibition of the demethylization of Ibenzmethyzine (Natulan) and monomethylhydrazine in the isolated perfused rat liver].
    Baggiolini M; Dewald B
    Helv Physiol Pharmacol Acta; 1966 Nov; 68():C72-4. PubMed ID: 5987886
    [No Abstract]   [Full Text] [Related]  

  • 7. An antineoplastic C14-labeled methylhydrazine derivative in P815 mouse leukemia. A metabolic study.
    Kreis W; Yen W
    Experientia; 1965 May; 21(5):284-6. PubMed ID: 5841267
    [No Abstract]   [Full Text] [Related]  

  • 8. Physiological disposition of 1-acetyl-2-picolinoylhydrazine (NSC68626) in rats bearing Walker carcinosarcoma 256.
    Mishra LC; Mead JA
    Cancer Res; 1973 Oct; 33(10):2393-7. PubMed ID: 4741934
    [No Abstract]   [Full Text] [Related]  

  • 9. Effect of SKF 525-A on the excretion of amine oxides by the rat.
    Dehner EW; Machinist JM; Ziegler DM
    Life Sci; 1968 Nov; 7(21):1135-46. PubMed ID: 5712725
    [No Abstract]   [Full Text] [Related]  

  • 10. [ON THE METABOLISM OF A CYTOSTATIC METHYLHYDRAZINE DERIVATIVE (NATULAN)].
    RAAFLAUB J; SCHWARTZ DE
    Experientia; 1965 Jan; 21():44-5. PubMed ID: 14283528
    [No Abstract]   [Full Text] [Related]  

  • 11. Metabolism of an antineoplastic methylhydrazine derivative in a P815 mouse neoplasm.
    Kreis W
    Cancer Res; 1970 Jan; 30(1):82-9. PubMed ID: 5441083
    [No Abstract]   [Full Text] [Related]  

  • 12. [A fundamentally new cytostatic: a methylhydrazine derivative (Natulan)].
    Hansen MM; Hertz H
    Ugeskr Laeger; 1966 Mar; 128(11):313-6. PubMed ID: 5331165
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences with a methylhydrazine derivative (Natulan)].
    Hertz H; Hansen MM; Videbaek AA
    Ugeskr Laeger; 1966 Mar; 128(11):316-24. PubMed ID: 5331015
    [No Abstract]   [Full Text] [Related]  

  • 14. Methane formation in vivo from N-isopropyl alpha(2-methylhydrazino)-p-toluamide hydrochloride, a tumor-inhibiting methylhydrazine derivative.
    Dost FN; Reed DJ
    Biochem Pharmacol; 1967 Sep; 16(9):1741-6. PubMed ID: 6053216
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on the effects of isoniazid on acetylhydrazine metabolism in vivo and in vitro.
    Timbrell JA; Wright JM
    Drug Metab Dispos; 1979; 7(4):237-40. PubMed ID: 39727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. N-demethylation of the antineoplastic agent hexamethylmelamine by rats and man.
    Worzalla JF; Johnson BM; Ramirez G; Bryan GT
    Cancer Res; 1973 Nov; 33(11):2810-5. PubMed ID: 4748436
    [No Abstract]   [Full Text] [Related]  

  • 17. [RESULTS OF CLINICAL TESTS OF A NEW CYTOSTATIC SUBSTANCE FROM THE METHYLHYDRAZINE SERIES (NATULAN)].
    BEGEMANN H; BLUM KU; FELLMER KE; FOELSCH E; GERHARTZ H; GRUNZE H; HAUSMANN K; HENNES R; JUENGLING W; KLEIBEL F; KOERTGE P; MARING H; MARTIN H; OBRECHT P; OSTEN W; PABST HW; POLIWODA H; SCHUBERT JC; SEIDL S; SPECHTER HJ; STRICKSTROCK KH; WITTE S; DREWS J
    Med Klin; 1965 Jun; 60():960-4. PubMed ID: 14304965
    [No Abstract]   [Full Text] [Related]  

  • 18. The pathway of catabolism of cytotoxic purinyl-6-substituted amines in vivo.
    Lettré H; Werner D
    Biochem Pharmacol; 1968 Sep; 17(9):1951-7. PubMed ID: 5688278
    [No Abstract]   [Full Text] [Related]  

  • 19. Metabolism of carbidopa (1-(-)-alpha-hydrazino-3,4-dihydroxy-alpha-methylhydrocinnamic acid monohydrate), an aromatic amino acid decarboxylase inhibitor, in the rat, rhesus monkey, and man.
    Vickers S; Stuart EK; Bianchine JR; Hucker HB; Jaffe ME; Rhodes RE; Vandenheuvel WJ
    Drug Metab Dispos; 1974; 2(1):9-22. PubMed ID: 4150141
    [No Abstract]   [Full Text] [Related]  

  • 20. [A new methylhydrazine derivative (Ro 4-6467 or Natulan) in the treatment of Hodgkin's disease. Study of 10 cases].
    da Silva MP; Kerbauy J; de Guerra CC
    Rev Bras Med; 1966 Jul; 23(7):483-9. PubMed ID: 6014416
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.